Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,137,500.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant:Bringing Rare Disease Gene Therapies to Clinical Trial Readiness
178790
The specific objectives of this funding opportunity are to:
• Increase and advance the development of gene therapies for rare disease clinical trials in Canada;
• Generate the evidence required for first-in-human clinical trials, in part by working with Canada’s biomanufacturing capacity (National Research Council of Canada) and health technology regulator (Health Canada); and,
• Increase current and future capacity across the Canadian rare disease landscape (i.e., among researchers, knowledge users, patient(s)/caregiver(s)/family) to improve readiness of gene therapies for first-in-human clinical trials.
$1,137,500.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant:Bringing Rare Disease Gene Therapies to Clinical Trial Readiness
178789
The specific objectives of this funding opportunity are to:
• Increase and advance the development of gene therapies for rare disease clinical trials in Canada;
• Generate the evidence required for first-in-human clinical trials, in part by working with Canada’s biomanufacturing capacity (National Research Council of Canada) and health technology regulator (Health Canada); and,
• Increase current and future capacity across the Canadian rare disease landscape (i.e., among researchers, knowledge users, patient(s)/caregiver(s)/family) to improve readiness of gene therapies for first-in-human clinical trials.
$1,137,500.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant:Bringing Rare Disease Gene Therapies to Clinical Trial Readiness
178788
The specific objectives of this funding opportunity are to:
• Increase and advance the development of gene therapies for rare disease clinical trials in Canada;
• Generate the evidence required for first-in-human clinical trials, in part by working with Canada’s biomanufacturing capacity (National Research Council of Canada) and health technology regulator (Health Canada); and,
• Increase current and future capacity across the Canadian rare disease landscape (i.e., among researchers, knowledge users, patient(s)/caregiver(s)/family) to improve readiness of gene therapies for first-in-human clinical trials.
$50,000.00
Apr 1, 2024
For-profit organization
ICAP 2024 – International Co-Innovation Action Plan
1016511
We are looking to identify co-innovation partners who are interested in improving patient adherence to therapy and other stakeholders (distributors & payers) that are interested in the German and Dutch markets.
$74,000.00
Apr 1, 2024
For-profit organization
Therapy Note Taking Platform
1016667
With this project, we’re creating a note taking platform guided by the expertise and guidance of a clinical expert. This new product will allow us to streamline our processes.
$49,300.00
Apr 1, 2024
For-profit organization
PACI
1017843
Development of a digital therapy for the management of neurodevelopmental disorders in children, in collaboration with a European partner.
$649,600.00
Apr 1, 2024
Indigenous recipients
Wiichihishoo Kawii Otinum La Fors Program
GV230367
Through this 24-month project, Métis Central Western Region 2 Council Incorporated will develop and put in place the Heartbeat Trauma Release Method Therapy (HTR) with Indigenous girls, two spirit and trans youth experiencing gender-based violence to strengthen the GBV sector.
$25,000.00
Mar 29, 2024
Not-for-profit organization or charity
The objectives of the Program are: .• promoting volunteerism among seniors; .• engaging seniors in the community through.mentoring of others; .• expanding awareness of elder abuse, including.financial abuse; .• supporting social participation and inclusion of.seniors; and .• providing capital assistance for new and existing.community projects and/or programs for seniors. .
$23,934.00
Mar 29, 2024
For-profit organization
The objectives of the Program are: .• promoting volunteerism among seniors; .• engaging seniors in the community through.mentoring of others; .• expanding awareness of elder abuse, including.financial abuse; .• supporting social participation and inclusion of.seniors; and .• providing capital assistance for new and existing.community projects and/or programs for seniors. .
$14,175.00
Mar 28, 2024
For-profit organization
Develop digital adoption plan